z-logo
open-access-imgOpen Access
Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa
Author(s) -
Barbara Frigerio,
Matilde Montermini,
Silvana Canevari,
Mariangela Figini
Publication year - 2022
Publication title -
antibody therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.579
H-Index - 5
ISSN - 2516-4236
DOI - 10.1093/abt/tbac026
Subject(s) - monoclonal antibody , chimeric antigen receptor , antibody , conjugate , antigen , folate receptor , cancer research , receptor , antibody drug conjugate , immunotherapy , biology , immunology , medicine , cancer , immune system , cancer cell , mathematical analysis , mathematics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom